Raymond James Issues Pessimistic Forecast for Integral Ad Science (NASDAQ:IAS) Stock Price

Integral Ad Science (NASDAQ:IAS - Free Report) had its price target decreased by Raymond James from $16.00 to $11.00 in a report published on Monday,Benzinga reports. Raymond James currently has an outperform rating on the stock.

Several other research analysts have also recently issued reports on IAS. Scotiabank initiated coverage on Integral Ad Science in a research note on Friday, February 28th. They issued a "sector perform" rating and a $12.00 price objective on the stock. Baird R W downgraded shares of Integral Ad Science from a "strong-buy" rating to a "hold" rating in a research report on Friday, March 28th. Stifel Nicolaus reduced their price target on shares of Integral Ad Science from $15.00 to $13.00 and set a "buy" rating for the company in a report on Wednesday, April 23rd. Barclays dropped their price objective on shares of Integral Ad Science from $14.00 to $7.00 and set an "equal weight" rating on the stock in a research note on Monday, April 21st. Finally, Morgan Stanley lowered their target price on Integral Ad Science from $13.50 to $12.50 and set an "equal weight" rating for the company in a report on Thursday, April 17th. Six research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $13.15.

Integral Ad Science Trading Down 0.9 %

Shares of IAS traded down $0.07 during mid-day trading on Monday, reaching $7.72. 1,389,653 shares of the company's stock traded hands, compared to its average volume of 1,035,584. The stock's 50-day moving average is $7.86 and its two-hundred day moving average is $9.75. Integral Ad Science has a 12 month low of $6.26 and a 12 month high of $13.62. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.71 and a quick ratio of 3.71. The stock has a market cap of $1.26 billion, a P/E ratio of 38.60, a P/E/G ratio of 1.06 and a beta of 1.55.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last posted its quarterly earnings results on Friday, February 28th. The company reported $0.09 EPS for the quarter, missing analysts' consensus estimates of $0.12 by ($0.03). The company had revenue of $153.00 million during the quarter, compared to the consensus estimate of $148.83 million. Integral Ad Science had a return on equity of 3.47% and a net margin of 6.39%. The company's revenue for the quarter was up 13.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.06 earnings per share. Research analysts forecast that Integral Ad Science will post 0.26 earnings per share for the current fiscal year.

Insider Buying and Selling at Integral Ad Science

In other Integral Ad Science news, CEO Lisa Utzschneider sold 8,547 shares of the company's stock in a transaction that occurred on Monday, April 7th. The shares were sold at an average price of $6.85, for a total transaction of $58,546.95. Following the transaction, the chief executive officer now owns 341,271 shares in the company, valued at approximately $2,337,706.35. This represents a 2.44 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Over the last ninety days, insiders sold 86,222 shares of company stock worth $636,252. 2.00% of the stock is owned by insiders.

Hedge Funds Weigh In On Integral Ad Science

Several hedge funds have recently made changes to their positions in the company. Alyeska Investment Group L.P. purchased a new position in shares of Integral Ad Science during the 4th quarter valued at about $41,543,000. Dimensional Fund Advisors LP raised its position in Integral Ad Science by 18.1% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,789,996 shares of the company's stock valued at $39,567,000 after acquiring an additional 580,323 shares in the last quarter. Clearline Capital LP purchased a new stake in Integral Ad Science in the 4th quarter worth approximately $3,949,000. Invenomic Capital Management LP boosted its position in Integral Ad Science by 52.9% in the 4th quarter. Invenomic Capital Management LP now owns 895,061 shares of the company's stock worth $9,344,000 after purchasing an additional 309,752 shares in the last quarter. Finally, Ararat Capital Management LP grew its stake in shares of Integral Ad Science by 13.4% during the 4th quarter. Ararat Capital Management LP now owns 2,281,912 shares of the company's stock worth $23,823,000 after purchasing an additional 269,346 shares during the period. 95.78% of the stock is owned by institutional investors and hedge funds.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.